Site Content

Product Information

Bordetella pertussis

As a Class 1 Device, Viramed Biotech has filed the B. pertussis Immunoblot for Clinical Testing.  This product is intented for InVitro Diagnostic use in the testing of human serum for the presence of human antibodies to B. pertussis PT (pertussis toxin) and FHA (Filamentous Hemagglutinin) antigens. The B. pertussis VIraStripe utilizes Bordetella specific antigens:FHA and PT. Every strip has an integrated control system including serum control, conjugate control, and cut-off control. The PT (28 kD) in charaterized specific for B. pertussis. The antigen FHA (220kD) is characterized specific for Bordetella species. 

Bordetella pertussis ViraStripe:     
B. Pertussis IgG ViraStripe​                                                       
V-BPSGOK  50 Determinations
B. Pertussis IgA ViraStripe
V-BPSAOK   50 Determinations

Controls and Reagents (for ViraStripe Use):
V-BPSGPK     B. pertussis IgG Positive Control
V-BPSAPK     B. pertussis IgA Positive Control
V-BPSPNK     B. pertussis Negative Control

Learn More


Borrelia B31 ViraStripe IgG  

Borrelia B31 ViraStripe IgM  

Bordetella pertusis ViraStripe IgG  

Bordetella pertussis ViraStripe IgA  

Helicobacter pylori ViraStripe IgG  

Helicobacter pylori ViraStripe IgA  

​Borrelia B31 ViraChip IgG     

Borrelia B31 ViraChip IgM